Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$1.1 - $2.23 $6,270 - $12,711
-5,700 Reduced 96.72%
193 $0
Q1 2022

May 05, 2022

SELL
$1.72 - $2.96 $63 - $109
-37 Reduced 0.62%
5,893 $12,000
Q4 2021

Feb 02, 2022

BUY
$2.35 - $9.95 $404 - $1,711
172 Added 2.99%
5,930 $17,000
Q3 2021

Nov 02, 2021

BUY
$9.31 - $13.25 $111 - $159
12 Added 0.21%
5,758 $56,000
Q2 2021

Aug 02, 2021

BUY
$13.02 - $17.83 $37,054 - $50,744
2,846 Added 98.14%
5,746 $75,000
Q1 2021

May 11, 2021

BUY
$15.01 - $25.74 $43,529 - $74,646
2,900 New
2,900 $52,000

About Angion Biomedica Corp.


  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.